These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 11216550)
1. Prevention of peritonitis in children on peritoneal dialysis. Verrina E; Honda M; Warady BA; Piraino B Perit Dial Int; 2000; 20(6):625-30. PubMed ID: 11216550 [TBL] [Abstract][Full Text] [Related]
2. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin. Caring for Australians with Renal Impairment (CARI) Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S86-90. PubMed ID: 15469567 [No Abstract] [Full Text] [Related]
3. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective? Piraino B Nephrol Dial Transplant; 2010 Feb; 25(2):349-52. PubMed ID: 19934078 [No Abstract] [Full Text] [Related]
4. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Jassal SV; Lok CE; Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950 [TBL] [Abstract][Full Text] [Related]
5. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Piraino B Am J Kidney Dis; 1990 Aug; 16(2):89-95. PubMed ID: 2200261 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Posthuma N; Borgstein PJ; Eijsbouts Q; ter Wee PM Nephrol Dial Transplant; 1998 Mar; 13(3):700-3. PubMed ID: 9550649 [TBL] [Abstract][Full Text] [Related]
14. The impact of exit-site care and catheter design on the incidence of catheter-related infections. Jones LL; Tweedy L; Warady BA Adv Perit Dial; 1995; 11():302-5. PubMed ID: 8534730 [TBL] [Abstract][Full Text] [Related]
15. Prevention of peritonitis in children receiving peritoneal dialysis. Auron A; Simon S; Andrews W; Jones L; Johnson S; Musharaf G; Warady BA Pediatr Nephrol; 2007 Apr; 22(4):578-85. PubMed ID: 17216260 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306 [TBL] [Abstract][Full Text] [Related]
17. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. Davenport A; J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients. Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858 [TBL] [Abstract][Full Text] [Related]
19. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248 [No Abstract] [Full Text] [Related]
20. Simultaneous removal and replacement of infected peritoneal dialysis catheters. Majkowski NL; Mendley SR Am J Kidney Dis; 1997 May; 29(5):706-11. PubMed ID: 9159304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]